What is NDC 27241-237?

27241-237 is the product NDC for Oxcarbazepine, Oxcarbazepine 150 mg/1 tablet, extended release, listed with the FDA by Ajanta Pharma USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Ajanta Pharma USA Inc., NDC labeler code 27241. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Oxcarbazepine?

118 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Oxcarbazepine NDC 27241-237 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)27241-237Labeler and product segments. Claims need a package NDC.

Product NDC at billing width27241-0237Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
27241-237-01	27241023701	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-237-01)Marketed from Feb 22, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Oxcarbazepine
Generic name (nonproprietary): oxcarbazepine
Active ingredients: Oxcarbazepine — 150 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Ajanta Pharma USA Inc.NDC labeler code 27241
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217659
Marketing start: Feb 22, 2024
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 27241-237_ffbd0c62-0cbd-4ea3-b1a1-1a40a16884e3SPL ID ffbd0c62-0cbd-4ea3-b1a1-1a40a16884e3SPL set ID d947e9b1-2a15-4048-bb4e-fe56b6851848RxCUI 1365653, 1365842, 1365844UNII VZI5B1W380UPC 0327241238017, 0327241239014, 0327241237010
Pharmacologic class: Anti-epileptic Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N427241023701 followed by a unit qualifier and the quantity

Package 27241-0237-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 30, 2025.

Indications (excerpt from the label)

Oxcarbazepine extended-release tablets are indicated for the treatment of partial-onset seizures in patients 6 years of age and older. Oxcarbazepine extended-release tablets are indicated for the treatment of partial-onset seizures in patients 6 years of age and older. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 27241-237

What is NDC 27241-237?: 27241-237 is the product NDC for Oxcarbazepine, Oxcarbazepine 150 mg/1 tablet, extended release, listed with the FDA by Ajanta Pharma USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Oxcarbazepine.
What is the active ingredient?: Oxcarbazepine.
Who is the labeler?: Ajanta Pharma USA Inc., NDC labeler code 27241. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Oxcarbazepine?: 118 other product NDCs are listed under this name. See all Oxcarbazepine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Oxcarbazepine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Oxcarbazepine	Oxcarbazepine 150 mg/1	Tablet, Film coatedOral	Zameer Pharmaceuticals LLC	90096-171	90096-0171-01
Oxcarbazepine	Oxcarbazepine 300 mg/1	Tablet, Film coatedOral	Zameer Pharmaceuticals LLC	90096-172	90096-0172-01
Oxcarbazepine	Oxcarbazepine 600 mg/1	Tablet, Film coatedOral	Zameer Pharmaceuticals LLC	90096-173	90096-0173-01
Oxcarbazepine	Oxcarbazepine 300 mg/5mL	SuspensionOral	Novadoz Pharmaceuticals LLC	72205-354	72205-0354-85
Oxcarbazepine	Oxcarbazepine 600 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4664	70518-4664-0070518-4664-01
Oxcarbazepine	Oxcarbazepine 300 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4663	70518-4663-0070518-4663-01
Oxcarbazepine	Oxcarbazepine 300 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-2084	67046-2084-03
Oxcarbazepine	Oxcarbazepine 300 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-0868	67046-0868-03
Oxcarbazepine	Oxcarbazepine 600 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-0179	67046-0179-03
Oxcarbazepine	Oxcarbazepine 150 mg/1	Tablet, Film coatedOral	Major Pharmaceuticals	0904-7593	00904-7593-61

All 119 Oxcarbazepine NDCs

Other NDCs under ANDA 217659

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217659
Product	Strength	Form · route	Labeler	Product NDC
Oxcarbazepine	Oxcarbazepine 300 mg/1	Tablet, Extended releaseOral	Ajanta Pharma USA Inc.	27241-238
Oxcarbazepine	Oxcarbazepine 600 mg/1	Tablet, Extended releaseOral	Ajanta Pharma USA Inc.	27241-239